Evidence-based supplements & herbs for Arthritis | Suppev
Evidence by health condition

Nutrients, herbs & natural products studied for Arthritis

14 PubMed clinical trials & meta-analyses analyzed

AI summary

Evidence stage: Meta-Analysis

Across the abstracts, the arthritis evidence base is dominated by human clinical trials and meta-analyses, especially for osteoarthritis and rheumatoid arthritis. Collagen-based supplements, curcumin/Curcuma longa extract, glucosamine/chondroitin, omega-3 fatty acids, and vitamin D were the most commonly studied compounds, with several reviews reporting improvements in pain, function, or inflammatory markers. Some individual trials were negative or mixed, such as krill oil for knee osteoarthritis, which did not improve pain versus placebo. Overall, the literature suggests that findings vary by compound, arthritis type, and outcome measured, and many interventions still have limited or low-quality evidence. This evidence is educational; it is not FDA-approved and is not medical advice.

Doses are those reported in the studies, not recommendations. Talk to your doctor before taking anything.

Collagen

Natural productModerate evidenceMeta-Analysis

Doses studied: Not specified in abstract

Duration: Not specified

Meta-analyses of randomized trials in knee osteoarthritis reported significant improvements in function and pain scores with oral collagen-based supplements versus placebo. One meta-analysis reported a reduction in total WOMAC score, and another found a significant decrease in stiffness, while pain and function results were not consistently significant across all analyses. The 2025 meta-analysis included 870 participants from 11 RCTs and found favorable pooled effects on both function and pain.

Curcumin / Curcuma longa extract / turmeric extracts

HerbModerate evidenceMeta-Analysis

Doses studied: 120 mg to 1500 mg

Duration: 4-36 weeks

Multiple systematic reviews and meta-analyses evaluated curcumin and Curcuma longa extract in arthritis, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, and gout/hyperuricemia. The abstracts report improvements in pain and inflammation outcomes, including reductions in visual analog pain scores and WOMAC measures in osteoarthritis, with generally comparable safety to placebo and some lower adverse event rates versus NSAIDs. Evidence quality was described as low in at least one review, and more randomized trials were noted as needed.

+14 more compounds studied

Unlock every compound with doses, duration, findings and sources.

Unlock with Premium
Suppev

The #1 Real Supplement Evidence App

SUPPEV is an educational platform providing scientific evidence summaries. It does not diagnose, treat, prevent, or cure any disease. Consult a healthcare professional before supplement use.

© 2026 Suppev · PubMed / NCBI · WADA

We use cookies to keep you signed in, remember your language and improve Suppev. See our Privacy Policy.